[1]
Gedebjerg, A. et al. 2012. IL-20, IL-21 and p40: Potential Biomarkers of Treatment Response for Ustekinumab. Acta Dermato-Venereologica. 93, 2 (Aug. 2012), 150–155. DOI:https://doi.org/10.2340/00015555-1440.